Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
13,397,783
-
Shares change
-
-119,100
-
Total reported value, excl. options
-
$92,978,298
-
Value change
-
-$1,099,194
-
Number of buys
-
9
-
Number of sells
-
-20
-
Price
-
$6.94
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2014
34 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2014.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,397,783 shares
.
Largest 10 shareholders include NEA Management Company, LLC (8,575,135 shares), WELLINGTON MANAGEMENT CO LLP (2,605,408 shares), FRANKLIN RESOURCES INC (917,985 shares), Cormorant Asset Management, LLC (472,300 shares), VANGUARD GROUP INC (203,165 shares), WALL STREET ASSOCIATES (150,000 shares), MASON STREET ADVISORS, LLC (101,985 shares), GOLDMAN SACHS GROUP INC (95,556 shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (55,844 shares), and GEODE CAPITAL MANAGEMENT, LLC (47,409 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.